Clinical trial
Spironolactone Combined With Captopril and Carvedilol for the Treatment of…
NCT00240656 · Hebei Medical University, Other · Completed
Key facts
| NCT number | NCT00240656 |
|---|---|
| Title | Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension |
| Official title | Official Title: Spironolactone Combined With Captopril and Carvedilol for the Treatment of Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease-Focus on Pulmonary Artery Remodeling |
| Lead sponsor | Hebei Medical University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hypertension, Pulmonary |
| Intervention type | Drug |
| Interventions | spironolactone captopril carvedilol |
| Start date | Oct 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Oct 18, 2005 |
| Last update posted | Jun 30, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: